Bailard, Inc. Cullinan Oncology, Inc. Transaction History

Bailard, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$7.89 - $10.23 $85,212 - $110,484	10,800 New	10,800 $110,000
Q1 2023 May 08, 2023	BUY	$10.2 - $11.91 $112,199 - $131,010	11,000 New	11,000 $112,000
Q4 2021 Feb 10, 2022	SELL	$15.36 - $25.0 $147,456 - $240,000	-9,600 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$22.56 - $29.68 $216,576 - $284,928	9,600 New	9,600 $217,000

146

67.6M

612K

118K

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $613M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.